InsiderDB
Sign inStart free trial

Sen. David Perdue sold Bristol-Myers Squibb Company (BMY)

Sen. David Perdue (R-GA) · $15K–$50K · traded Aug 15, 2019

Transaction
Sold (partial)
Amount
$15K–$50K
Owner
Joint
Traded
Aug 15, 2019
Disclosed
Sep 3, 2019
Days to disclose
19
Asset type
Stock
As filed
Bristol-Myers Squibb Company
Industry
Drug Manufacturers - General · Healthcare
Official filing ↗All of Perdue's tradesAll Congress trades in BMY

Other trades in this filing

All of Perdue's trades →

Recent Congress trades in BMY

Company context for BMY

Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.

  1. BMYFinancial report·SEC EDGAR

    BMY: 10-Q financial filing

    Filed 10-Q for an event or period dated 2026-09-30. Read the company report for its disclosures.

    Public: Oct 29, 2026, 11:16 AM EDTEvent / period: Sep 30, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  2. BMYCompany announcement·SEC EDGAR

    BMY: Financial results · Company disclosure

    Filed 8-K for an event or period dated 2026-10-29. Financial results; Company disclosure.

    Public: Oct 29, 2026, 7:05 AM EDTEvent / period: Oct 29, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  3. BMYLobbying report·Lobbying disclosures

    BMY: third_quarter 2026 lobbying report

    Access to prescription drugs. Policies related to 340B. Drug Pricing reform/implementation. Food is Medicine initiatives. Issues related to the budget and appropriations process

    Public: Oct 20, 2026, 11:15 PM EDTOriginal source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.